GENETIC TECHNOLOGIES LIMITED — Director's Dealing 2019

Jun 4, 2019

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Genetic Technologies Limited ABN 17 009 212 328

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Samuel Xue Lee
Date of last notice	31 January 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Name of Director	Samuel Xue Lee	Samuel Xue Lee
	Date of last notice	31 January 2018
Part 1 - Change of director’s relevant interests in securitiesIn the case of a trust, this includes interests in the trust made available by the responsible entity of the trustNote: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” shouldbe disclosed in this part.Direct or indirect interestDirectNature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.Date of change13 May 2019
	Direct or indirect interest		Direct
	Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
	Date of change		13 May 2019
	No. of securities held prior to change		59,594,850 ordinary shares (representedby 397,299American DepositaryReceipts)
	Class		Ordinary shares
	Number acquired
	Number disposed		59,594,850 ordinary shares (representedby 397,299 American Depositary Receipts)
	Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation		USD 478,916 (AUD 684,166 approx.)
	No. of securities held after change		Nil

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change On-market trade Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 317] intentionally omitted <==

----- Start of picture text ----- Detail of contractNature of interestName of registered holder(if issued securities)Date of changeNo. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changedInterest acquiredInterest disposedValue/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuationInterest after change----- End of picture text -----

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed Yes above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade No to proceed during this period? If prior written clearance was provided, on what date was this N.A. provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011